Selective osteoblast overexpression of IGF-I in mice prevents low protein-induced deterioration of bone strength and material level properties

Bone

Volumn 49, Issue 5, 2011, Pages 1073-1079

  Brennan Speranza, Tara C ^a   Rizzoli, René ^a   Kream, Barbara E ^b   Rosen, Clifford ^c   Ammann, Patrick ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^c Maine Medical Center Research Institute   (United States)

Author keywords

Bone strength; Osteoblastic IGF I; Protein undernutrition

Indexed keywords

OSTEOCALCIN; SOMATOMEDIN C;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOMECHANICS; BODY WEIGHT; BONE STRENGTH; BONE STRUCTURE; CONTROLLED STUDY; CORTICAL BONE; MALE; MORPHOMETRICS; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; PROTEIN BLOOD LEVEL; PROTEIN DIET; PROTEIN EXPRESSION; PROTEIN RESTRICTION; TIBIA; VERTEBRA; WEIGHT REDUCTION; WILD TYPE;

ANIMALS; BIOMECHANICS; BONE AND BONES; DIETARY PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; INSULIN-LIKE GROWTH FACTOR I; MICE; MICE, TRANSGENIC; OSTEOBLASTS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 80054840237     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2011.07.039     Document Type: Article

References (32)

1. Rizzoli R., Ammann P., Chevally T., Bonjour J.-P. Effects of dietary protein insufficiency on the skeleton. Nutritional aspects of bone health 2003, 193-212. The Royal Society of Chemistry, Cambridge. S.A. New, J.-P. Bonjour (Eds.).
2. Rizzoli R., Bonjour J.-P. Dietary protein and bone health. J Bone Miner Res 2004, 19:527-531.
3. Rizzoli R. Nutrition: its role in bone health. Best Pract Res Clin Endocrinol Metab 2008, 22:813-829.
4. Veldhuis J.D. Aging and hormones of the hypothalamo-pituitary axis: gonadotropic axis in men and somatotropic axes in men and women. Ageing Res Rev 2008, 7:189-208.
5. Hammerman M.R. Insulin-like growth factors and aging. Endocrinol Metab Clin North Am 1987, 16:995.
6. Chevalley T., Hoffmeyer P., Bonjour J.-P., Rizzoli R. Early serum IGF-I response to oral protein supplements in elderly women with a recent hip fracture. Clin Nutr 2010, 29:78-83.
7. Chevalley T., Rizzoli R., Manen D., Caverzasio J., Bonjour J.P. Arginine increases insulin-like growth factor-I production and collagen synthesis in osteoblast-like cells. Bone 1998, 23:103-109.
8. Rosen C.J., Niu T. Growth hormone and insulin-like growth factors: potential applications and limitations in the management of osteoporosis. Osteoporosis 2008, 1809-1836. Alsevier, Inc., Burlington. F. Marcus, Nelson, Rosen (Eds.).
9. Bourrin S., Toromanoff A., Ammann P., Bonjour J.P., Rizzoli R. Dietary protein deficiency induces osteoporosis in aged male rats. J Bone Miner Res 2000, 15:1555-1563.
10. Bourrin S., Ammann P., Bonjour J.P., Rizzoli R. Dietary protein restriction lowers plasma insulin-like growth factor I (IGF-I), impairs cortical bone formation, and induces osteoblastic resistance to IGF-I in adult female rats. Endocrinology 2000, 141:3149-3155.
11. Ammann P., Bourrin S., Bonjour J.P., Meyer J.M., Rizzoli R. Protein undernutrition-induced bone loss is associated with decreased IGF-I levels and estrogen deficiency. J Bone Miner Res 2000, 15:683-690.
12. Ammann P., Brennan T.C., Mekraldi S., Aubert M.L., Rizzoli R. Administration of growth hormone in selectively protein-deprived rats decreases BMD and bone strength. Bone 2010, 46:1574-1581.
13. De-Wolf E., Gill R., Geddes S., Pitts J., Wollmer A., Grotzinger J. Solution structure of a mini IGF-1. Protein Sci 1996, 5:2193-2202.
14. Lund P.K. Insulin-like growth factor I: molecular biology and relevance to tissue-specific expression and action. Recent Prog Horm Res 1994, 49:125-148.
15. Slater M., Patava J., Kingham K., Mason R.S. Modulation of growth factor incorporation into ECM of human osteoblast-like cells in vitro by 17 beta-estradiol. Am J Physiol 1994, 267:E990-E1001.
16. Wong G.L., Kotliar D., Schlaeger D., Brandes S.J. IGF-I production by mouse osteoblasts. J Bone Miner Res 1990, 5:133-140.
17. Liu J.P., Baker J., Perkins A.S., Robertson E.J., Efstratiadis A. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 1993, 75:59-72.
18. Clemmons D.R. Modifying IGF1 activity: an approach to treat endocrine disorders, atherosclerosis and cancer. Nat Rev Drug Discov 2007, 6:821-833.
19. Vardatsikos G., Sahu A., Srivastava A. The insulin-like growth factor family: molecular mechanisms, redox regulation and clinical implications. Antioxid Redox Signal 2009, 11:1165-1190.
20. Yakar S., Rosen C.J. From mouse to man: redefining the role of insulin-like growth factor-I in the acquisition of bone mass. Exp Biol Med 2003, 228:245-252.
21. Canalis E., Rydziel S., Delany A., Varghese S., Jeffrey J. Insulin-like growth factors inhibit interstitial collagenase synthesis in bone cell cultures. Endocrinology 1995, 136:1348-1354.
22. Jiang J., Lichtler A.C., Gronowicz G.A., Adams D.J., Clark S.H., Rosen C.J., et al. Transgenic mice with osteoblast-targeted insulin-like growth factor-I show increased bone remodeling. Bone 2006, 39:494-504.
23. Laib A., Barou O., Vico L., Lafage-Proust M.H., Alexandre C., Rügsegger P. 3D micro-computed tomography of trabecular and cortical bone architecture with application to a rat model of immobilisation osteoporosis. Med Biol Eng Comput 2000, 38:326-332.
24. Bagi C.M., Hanson N., Andresen C., Pero R., Lariviere R., Turner C.H., et al. The use of micro-CT to evaluate cortical bone geometry and strength in nude rats: correlation with mechanical testing, pQCT and DXA. Bone 2006, 38:136-144.
25. Ammann P., Badoud I., Barraud S., Dayer R., Rizzoli R. Strontium ranelate treatment improves trabecular and cortical intrinsic bone tissue quality, a determinant of bone strength. J Bone Miner Res 2007, 22:1419-1425.
26. Chappard D., Palle S., Alexandre C., Vico L., Riffat G. Bone embedding in pure methyl methacrylate at low temperature preserves enzyme activities. Acta Histochem 1987, 81:183-190.
27. Parfitt A.M., Drezner M.K., Glorieux F.H., Kanis J.A., Malluche H., Meunier P.J., et al. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 1987, 2:595-610.
28. Zhao G., Monier-Faugere M.-C., Langub M.C., Geng Z., Nakayama T., Pike J.W., et al. Targeted overexpression of insulin-like growth factor I to osteoblasts of transgenic mice: increased trabecular bone volume without increased osteoblast proliferation. Endocrinology 2000, 141:2674-2682.
29. Rutter M.M., Markoff E., Clayton L., Akeno N., Zhao G., Clemens T.L., et al. Osteoblast-specific expression of insulin-like growth factor-1 in bone of transgenic mice induces insulin-like growth factor binding protein-5. Bone 2005, 36:224-231.
30. Rodondi A., Ammann P., Ghilardi-Beuret S., Rizzoli R. Zinc increases the effects of essential amino acids-whey protein supplements in frail elderly. J Nutr Health Ageing 2009, 13:491-497.
31. Dubois-Ferrière V., Brennan T.C., Dayer R., Rizzoli R., Ammann P. Calcitropic hormones and IGF-I are influenced by dietary protein. Endocrinology 2011, 152:1839-1847.
32. Jones J.I., Clemmons D.R. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 1995, 16:3-34.